Effects of a stepwise multidisciplinary intervention for challenging behavior in advanced dementia: A cluster randomized controlled trial

Journal of the American Geriatrics Society

Volumn 64, Issue 2, 2016, Pages 261-269

  Pieper, Marjoleine J C ^a,b,c   Francke, Anneke L ^a,d   Van Der Steen, Jenny T ^a,b   Scherder, Erik J A ^e   Twisk, Jos W R ^b   Kovach, Christine R ^f   Achterberg, Wilco P ^a,c  

^a UNIVERSITY OF AMSTERDAM   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d NETHERLANDS INSTITUTE FOR HEALTH SERVICES RESEARCH   (Netherlands)

^e VU UNIVERSITY AMSTERDAM   (Netherlands)

^f UNIVERSITY OF WISCONSIN MILWAUKEE   (United States)

Author keywords

Challenging behavior; Dementia; Nursing home; Psychotropic drug use; Stepwise approach

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; HYPNOTIC SEDATIVE AGENT; NEUROLEPTIC AGENT; NOOTROPIC AGENT; PSYCHOTROPIC AGENT;

AGED; AGITATION; ARTICLE; BEHAVIOR DISORDER; CLINICAL EFFECTIVENESS; COHEN MANSFIELD AGITATION INVENTORY; CONTROLLED STUDY; CORNELL SCALE FOR DEPRESSION IN DEMENTIA; DEMENTIA; DEPRESSION; FEMALE; GENERAL MENTAL DISEASE ASSESSMENT; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL STAFF; MOOD; MULTICENTER STUDY; NETHERLANDS; NEUROPSYCHIATRIC INVENTORY NURSING HOME; NURSING HOME; NURSING HOME PATIENT; PAIN; RANDOMIZED CONTROLLED TRIAL; VERY ELDERLY; COMORBIDITY; COMPLICATION; NEEDS ASSESSMENT; PAIN MEASUREMENT; PSYCHOLOGICAL RATING SCALE; PSYCHOMOTOR AGITATION; TREATMENT OUTCOME;

AGED, 80 AND OVER; COMORBIDITY; DEMENTIA; DEPRESSION; FEMALE; HUMANS; MALE; NEEDS ASSESSMENT; NETHERLANDS; NURSING HOMES; PAIN MEASUREMENT; PSYCHIATRIC STATUS RATING SCALES; PSYCHOMOTOR AGITATION; PSYCHOTROPIC DRUGS; TREATMENT OUTCOME;

EID: 84958881359     PISSN: 00028614     EISSN: 15325415     Source Type: Journal    
DOI: 10.1111/jgs.13868     Document Type: Article

References (34)

1. Ballard CG, O'Brien JT, Swann AG, et al., The natural history of psychosis and depression in dementia with Lewy bodies and Alzheimer's disease: Persistence and new cases over 1 year of follow-up. J Clin Psychiatry 2001; 62: 46-49.
2. Brodaty H, Connors MH, Xu J, et al., Predictors of institutionalization in dementia: A three year longitudinal study. J Alzheimers Dis 2014; 40: 221-226.
3. Luppa M, Luck T, Weyerer S, et al., Prediction of institutionalization in the elderly. A systematic review. Age Ageing 2010; 39: 31-38.
4. Gaugler JE, Yu F, Krichbaum K, et al., Predictors of nursing home admission for persons with dementia. Med Care 2009; 47: 191-198.
5. Wetzels RB, Zuidema SU, de Jonghe JF, et al., Course of neuropsychiatric symptoms in residents with dementia in nursing homes over 2-year period. Am J Geriatr Psychiatry 2010; 18: 1054-1065.
6. Briesacher BA, Limcangco MR, Simoni-Wastila L, et al., The quality of antipsychotic drug prescribing in nursing homes. Arch Intern Med 2005; 165: 1280-1285.
7. Steinberg M, Corcoran C, Tschanz JT, et al., Risk factors for neuropsychiatric symptoms in dementia: The Cache County Study. Int J Geriatr Psychiatry 2006; 21: 824-830.
8. Cohen-Mansfield J,. Nonpharmacologic treatment of behavioral disorders in dementia. Curr Treat Options Neurol 2013; 15: 765-785.
9. Pieper MJ, van Dalen-Kok AH, Francke AL, et al., Interventions targeting pain or behaviour in dementia: A systematic review. Ageing Res Rev 2013; 12: 1042-1055.
10. Kovach CR, Noonan PE, Schlidt AM, et al., The Serial Trial Intervention: An innovative approach to meeting needs of individuals with dementia. J Gerontol Nurs 2006; 32: 18-25; quiz 26-27.
11. Conroy S, Van Der Cammen T, Schols J, et al., Medical services for older people in nursing homes-comparing services in England and the Netherlands. J Nutr Health Aging 2009; 13: 559-563.
12. Ribbe MW, Ljunggren G, Steel K, et al., Nursing homes in 10 nations: A comparison between countries and settings. Age Ageing 1997; 26 (Suppl 2): 3-12.
13. Pieper MJC, Achterberg WP, Francke AL, et al., The implementation of the serial trial intervention for pain and challenging behaviour in advanced dementia patients (STA OP!): A clustered randomized controlled trial. BMC Geriatr 2011; 11: 12.
14. Koopmans RT, Lavrijsen JC, Hoek F,. Concrete steps toward academic medicine in long term care. J Am Med Dir Assoc 2013; 14: 781-783.
15. Reisberg B, Ferris SH, de Leon MJ, et al., The Global Deterioration Scale for assessment of primary degenerative dementia. Am J Psychiatry 1982; 139: 1136-1139.
16. Cohen-Mansfield J, Marx MS, Rosenthal AS,. A description of agitation in a nursing home. J Gerontol 1989; 44: M77-M84.
17. Cummings JL, Mega M, Gray K, et al., The Neuropsychiatric Inventory: Comprehensive assessment of psychopathology in dementia. Neurology 1994; 44: 2308-2314.
18. de Jonghe JF, Kat MG,. Factor structure and validity of the Dutch version of the Cohen-Mansfield Agitation Inventory (CMAI-D). J Am Geriatr Soc 1996; 44: 888-889.
19. Zuidema SU, de Jonghe JF, Verhey FR, et al., Agitation in Dutch institutionalized patients with dementia: Factor analysis of the Dutch version of the Cohen-Mansfield Agitation Inventory. Dement Geriatr Cogn Disord 2007; 23: 35-41.
20. Cohen-Mansfield J, Libin A,. Assessment of agitation in elderly patients with dementia: Correlations between informant rating and direct observation. Int J Geriatr Psychiatry 2004; 19: 881-891.
21. Wood S, Cummings JL, Hsu MA, et al., The use of the neuropsychiatric inventory in nursing home residents. Characterization and measurement. Am J Geriatr Psychiatry 2000; 8: 75-83.
22. Kat MG, de Jonghe JF, Aalten P, et al., [Neuropsychiatric symptoms of dementia: psychometric aspects of the Dutch Neuropsychiatric Inventory (NPI)]. Tijdschr Gerontol Geriatr 2002; 33: 150-155.
23. Alexopoulos GS, Abrams RC, Young RC, et al., Cornell Scale for Depression in Dementia. Biol Psychiatry 1988; 23: 271-284.
24. Burrows AB, Morris JN, Simon SE, et al., Development of a Minimum Data Set-based depression rating scale for use in nursing homes. Age Ageing 2000; 29: 165-172.
25. WHO Collaborating Center for Drug Statistics Methodology [on-line]. Available at http://www.whocc.no/atc-ddd-methodology/history/ Accessed February 1, 2014.
26. van Kleef M, Geurts JW,. Useful guideline for treatment of pain in vulnerable elderly people. Ned Tijdschr Geneeskd 2012; 155: A4933.
27. Eldridge SM, Ashby D, Kerry S,. Sample size for cluster randomized trials: Effect of coefficient of variation of cluster size and analysis method. Int J Epidemiol 2006; 35: 1292-1300.
28. Twisk JWR,. Applied Longitudinal Data Analysis for Epidemiology, 2nd Ed. Cambridge, UK: Cambridge University Press, 2013.
29. Rasbash J, Charlton C, Browne WJ, et al., MLwiN Version 2.1. Bristol, UK: Centre for Multilevel Modelling, University of Bristol, 2009.
30. Prince M, Bryce R, Albanese E, et al., The global prevalence of dementia: A systematic review and metaanalysis. Alzheimers Dement 2013; 9: 63.e62-75.e62.
31. Ballard CG, Gauthier S, Cummings JL, et al., Management of agitation and aggression associated with Alzheimer disease. Nat Rev Neurol 2009; 5: 245-255.
32. Porsteinsson AP, Drye LT, Pollock BG, et al., Effect of citalopram on agitation in Alzheimer disease: The CitAD randomized clinical trial. JAMA 2014; 311: 682-691.
33. Fossey J, Ballard C, Juszczak E, et al., Effect of enhanced psychosocial care on antipsychotic use in nursing home residents with severe dementia: Cluster randomised trial. BMJ 2006; 332: 756-761.
34. Zuidema SU, de Jonghe JF, Verhey FR, et al., Psychotropic drug prescription in nursing home patients with dementia: Influence of environmental correlates and staff distress on physicians' prescription behavior. Int Psychogeriatr 2011; 23: 1632-1639.